Diagnostics

Proteomics International has developed a versatile platform technology for discovering diagnostic tests based on the differences in the protein make-up of people with and without a particular disease. By comparing blood or other samples taken from both sick and healthy people, the Company is able to produce a set of “biomarkers”- biological signatures that can be used to test for a particular condition.

Subscribe
  • This field is for validation purposes and should be left unchanged.